본문 바로가기
KERD
논문KCI 등재

프로바이오틱스의 임상적 효과와 작용 기작

Probiotics : Action Mechanisms and Clinical Effects

1

조회

0

다운로드

4

인용

0

참고문헌

주제분류소아과학

초록

Abstract

The establishment of balanced intestinal microbial flora bears importance in maintaining the well-being of the human host. In this context, probiotics improving the intestinal microflora confer a beneficial effect on human health when ingested as live microorganisms. Bifidobacterium and Lactobacillus are mainly used as probiotics in the pharmaceuticals or functional foods. On review of the papers published in the scientific journals, prophylactic use of probiotics was promising in reducing both the incidence and severity of necrotizing enterocolitis in preterm neonates, alleviating rotavirus infection and preventing the atopy symptoms in children. The efficacy of the probiotics with respect to the inflammatory disease such as Crohn's disease and ulcerative colitis are being studied. Analysis of the various cytokines and immune markers are being conducted to understand the mechanism of action of the probiotics related to allergy and inflammation. More clinical studies are needed based on appropriate and well-conducted trials with known strains and doses since the efficacy varies depending on the specific probiotic strains or doses. Some of the species or strains distributed in probiotic markets raised some safety concerns such as causing human infections or transmitting antibiotic resistance genes. Therefore continued efforts to improve strain characteristics with respect to the efficacy through evidence-based human studies and evaluation of the safety are desired.

참고문헌 (118)

  1. "Ecology of bifidobacteria Biochemistry and physiology of bifidobacteria", pp.29~72 (1989), CRC press
  2. "Probiotics in man and animals", 66, pp.365~78 (1989)
  3. "Mechanism of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells", 126, pp.1054~70 (2004)
  4. "Role of intestinal bacterial flora in oral tolerance induction", 19, pp.907~14 (2004)
  5. "The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction", 159, pp.1739~45 (1997)
  6. "Functional foods:mechanisms of action on immunocompetent cells", 56 (1998)
  7. "Intestinal microflora and the interaction with immunocompetent cells", 67, pp.199~205 (1999)
  8. "Bacterial regulation of intestinal immune responses", 6, pp.116~22 (2000)
  9. "The intestinal microflora in allergic Estonian and Swedish 2-year-old children", 29, pp.342~6 (1999)
  10. "Allergy development and the intestinal microflora during the first year of life", 108, pp.516~20 (2001)
  11. "Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing", 107, pp.129~34 (2001)
  12. "Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects", pp.587~91
  13. "Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants", 30, pp.43~7 (2001)
  14. "Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria", pp.1~32 (2001)
  15. "Report of Joint FAO", WHO Working Group on Drafting guide lines for the evaluation of probiotics in food, 2002, ~
  16. "Evidence for safety and efficacy of finished natural health products" (2003)
  17. "Hepatic abscess and bacteremia due to Lactobacillus rhamnosus", 35, pp.100~1 (2003)
  18. "Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L", 28, pp.1159~60 (1999)
  19. "Lactobacillus endocarditis caused by a probiotic organism", rham(sus), pp.290~2
  20. "Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion", 33, pp.710~4 (2001)
  21. "Saccharomyces cerevisiae fungemia:an emerging infectious disease", 40, pp.1625~34 (2005)
  22. "Saccharomyces boulardii induced sepsis:successful therapy with voriconazole after treatment failure with fluconazole", 37, pp.69~72 (2005)
  23. "Numbers and strains of lactobacilli in some probiotic products", 97, pp.147~56 (2004)
  24. "Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns", 144, pp.186~90 (1985)
  25. "Bacterial colonization of neonates admitted to an intensive care environment", 93, pp.288~93 (1978)
  26. "Early administration of Bifidobacterium breve to preterm infants:randomised controlled trial", 76, pp.~7
  27. "Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants", 115, pp.1~4 (2005)
  28. "Oral probiotics prevent necrotizing enterocoloitis in very low birth weight neonates", 147, pp.143~6 (2005)
  29. "Probiotics feeding in prevention of urinary tract infection bacterial sepsis and necrotizing enterocolitis in preterm infants", pp.103~8
  30. "Enteral feeding of premature infants with Lactobacillus GG", 69, pp.483~7 (1993)
  31. "Oligofructose and experimental model of neonatal necrotising enterocolitis", 87 suppl 2, pp.213~9 (2002)
  32. "Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection", 115, pp.148~53 (2004)
  33. "Influence of nutritional status on the effectiveness of a dietary supplement of live Lactobacillus to prevent and cure diarrhoea in children", 54, pp.287~92 (2004)
  34. "Effect of probiotic infant formula on infections in child care centers:comparison of two probiotic agents", 115, pp.174~7 (2005)
  35. "Effects of long-term consumption of a fermented infant formula(with Bifidobacterium breve c50 and Streptococcus thermophilus 065)on acute diarrhea in healthy infants", 39, pp.147~52 (2004)
  36. "Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea:a randomized,double-blind,placebo controlled clinical trial", 4, pp.18~ (2004)
  37. "Long-term consumption of infant formulas containing live probiotic bacteria:tolerance and safety", 79, pp.261~7 (2004)
  38. "Probiotics for treating infectious diarrhoea"
  39. "Pathogenesis of intestinal and systemic rotavirus infection", 78, pp.10213~20 (2004)
  40. "Viral infections of the intestine", pp.566~78 (1988), Medical examination publishing company
  41. "The epithelial cell response to rotavirus infection", 163, pp.4442~52 (1999)
  42. "Rotavirus stimulates IL-8 secretion from cultured epithelial cells", 221, pp.251~9 (1996)
  43. "Human intestinal intraepithelial lymphocytes have potent chemotatic activity", 109, pp.1154~9 (1995)
  44. "Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens", 28, pp.405~40 (2004)
  45. "Probiotics in the third millennium", 34 suppl 2, pp.2~7 (2002)
  46. "Immune responses in rhesus rotavirus-challenged BALB", c mice treated with bifidobacteria and prebiotic supplements, 2002, pp.51, 750~5
  47. "Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model", 33, pp.171~7 (2001)
  48. "Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula", 82 suppl 1, pp.43~8 (1999)
  49. "Immunomodulatory function of lactic acid bacteria", 76, pp.383~9 (1999)
  50. "Fatal and near fatal anaphylactic reactions to food in children and adolescents", 372, pp.380~4 (1992)
  51. "The incidence of food allergy in atopic dermatitis", 50, pp.621~8 (2001)
  52. "Prevalences of symptoms of asthma and other allergic diseases in Korean children:a nationwide questionnaire survey", 16, pp.155~64 (2001)
  53. "Does a higher number of siblings protect against the development of allergy and asthma", pp.209~17
  54. "Allergy among school children in a Swedish country", 37 suppl 1, pp.5~6 (1982)
  55. "Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood", 103, pp.125~38 (1999)
  56. "Atopic dermatitis and the hygiene hypothesis:too clean to be true", 152, pp.202~16 (2005)
  57. "Environmental exposure to endotoxin and its relation to asthma in school-age children", 109, pp.379~92 (2002)
  58. "T helper cells engineered to produce latent TGF-beta 1 reverse allergen induced airway hyper reactivity and inflammation", pp.61~70
  59. "Allergy:the price we pay for cleaner living", 90, pp.64~70 (2003)
  60. "Reduced transforming growth factor- beta 1-producing T cells in the duodenal mucosa of children with food allergy", pp.2307~15
  61. "Preventive and curative effects of probiotics in atopic patients", 64, pp.1089~92 (2005)
  62. "Nutritional impact of pre- and probiotics as protective gastrointestinal organisms", 22, pp.107~38 (2002)
  63. "Atopy in children of families with an anthroposophic lifestyle", 353, pp.1485~8 (1999)
  64. "Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis", 52, pp.20~30 (2003)
  65. "Probiotics in the management of atopic eczema", 30, pp.1605~10 (2000)
  66. "Effect of probiotic Lactobacillus strains in children with atopic dermatitis", 111, pp.389~95 (2003)
  67. "Probiotics:a novel approach in the management of food allergy", 99, pp.179~85 (1997)
  68. "The influence of chronic yogurt consumption on immunity", 129 suppl 7, pp.1492~5 (1999)
  69. "Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects", 36, pp.118~2 (2004)
  70. "Probiotics in primary prevention of atopic disease:a randomized placebo-controlled trial", 357, pp.1076~9 (2001)
  71. "Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis", 145, pp.612~6 (2004)
  72. "Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant", 109, pp.119~21 (2002)
  73. "Clinical manifestions of pediatric inflammatory bowel disease", pp.326~34, Saunders Company 2000
  74. "Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease", 40, pp.681~4 (2004)
  75. "Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration", 20, pp.813~9 (2004)
  76. "Probiotics:an overview of beneficial effects", 82, pp.279~89 (2002)
  77. "Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria", 51, pp.659~64 (2002)
  78. "Treatment of murine colitis by Lactococcus lactis secreting interleukin-10", 289, pp.1352~5 (2000)
  79. "Lactobacillus GG in inducing and maintaining remission of Crohn's disease", 4, pp.5~ (2004)
  80. "Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease:a randomized controlled trial with Lactobacillus GG", 51, pp.405~9 (2002)
  81. "initiates resolution of inflammation in patients with active ulcerative colitis", pp.242~9
  82. "Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis", 22, pp.56~63 (2003)
  83. "VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis", 100, pp.1539~46 (2005)
  84. "Probiotics - role in inflammatory bowel disease", 34 suppl 2, pp.58~62 (2002)
  85. "Prophylaxis of pouchitis onset with probiotic therapy:a double-blind,placebo-controlled trial", 124, pp.1202~9 (2003)
  86. "Probiotic therapy in the prevention of pouchitis onset:decreased interleukin-1beta,interleukin-8,and interferon-gamma gene expression", 11, pp.447~54 (2005)
  87. "Probiotic therapy of intestinal inflammation and infections", 21, pp.44~50 (2005)
  88. "Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouchanal-anastomosis in ulcerative colitis", 40, pp.43~51 (2005)
  89. "Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora", 17, pp.509~15 (2003)
  90. "The immunological and genetic basis of inflammatory bowel disease", 3, pp.521~33 (2003)
  91. "Experimental models of intestinal inflammation New insights into mechanisms of mucosal homeostasis Handbook of mucosal immunology", pp.1007~24 (1999), Academic Press
  92. "Inflammatory bowel disease:etiology and pathogenesis", 115, pp.182~205 (1998)
  93. "Microbial factors in the pathogenesis of Crohn's disease", pp.96~104 (1995)
  94. "The bacterial flora in inflammatory bowel disease:current insights in pathogenesis and the influence of antibiotics and probiotics", 36 suppl 234, pp.29~40 (2001)
  95. "Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease", 169, pp.5308~14 (2002)
  96. "The current future understanding of inflammatory bowel disease", 16, pp.933~43 (2002)
  97. "Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis", 116, pp.301~9 (1999)
  98. "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis", 118, pp.229~41 (2004)
  99. "Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria", 303, pp.1662~5 (2004)
  100. "Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells", 168, pp.171~8 (2002)
  101. "Bacterial probiotic modulation of dendritic cells", 72, pp.3299~309 (2004)
  102. "Colonic epithelial cell turnover:possible implications for uncreative colitis and cancer initiation", 3, pp.201~11 (2004)
  103. "Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium", 160, pp.165~73 (2002)
  104. "Toll-like receptor 9 signalling mediates the anti-inflammatory effects of probiotics in murine experimental colitis", 126, pp.520~8 (2004)
  105. "ComPPARtmentalizing NF-κB in the gut", 5, pp.14~16 (2004)
  106. "Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA", 5, pp.104~12 (2004)
  107. "lymphokine secretion profiles in inflammatory bowel disease Crohn's disease LP cells manifest increased secretion of IFN-gamma whereas ulcerative colitis LP cells manifest increased secretion of IL-5", pp.1261~70
  108. "Control of intestinal inflammation by regulatory T cells", 3, pp.929~35 (2001)
  109. "Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport", 53, pp.821~8 (2004)
  110. "Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1", Yit strain mice, 2001, pp.64, 92~9
  111. "Double blind,placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance", 52, pp.975~80 (2003)
  112. "Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis", 13, pp.841~50 (2001)
  113. "CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice", 166, pp.6972~81 (2001)
  114. "The dendritic cell:its role in intestinal inflammation and relationship with gut bacteria", 52, pp.1522~9 (2003)
  115. "Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells", 6, pp.507~14 (2005)
  116. "Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria", pp.361~7
  117. "A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes", 191, pp.435~43 (2000)
  118. "A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes", 191, pp.435~43 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (13건)